Merz Pharmaceuticals (Merz Pharma
GmbH & Co.
KGaA), a member of
Merz Pharma, is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in
Germany, Merz is a leader in the field of
Alzheimer's disease research and developed
memantine as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology.
External links